drugset / Trial / NCT00723918
Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy
Phase 2
Withdrawn
Washington University School of Medicine
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness of methadone alone and in combination with SAB378 for the treatment of painful HIV-associated neuropathy.
Timeline
- Start
- 2009-04
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methadone | Other / unclassified | 10 mg | — |
| Subject | Nabiximols | Other / unclassified | 15 mg | — |